Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvalent (NUVL) Gains from Sales and Divestitures (2022 - 2026)

Nuvalent filings provide 3 years of Gains from Sales and Divestitures readings, the most recent being $309133.0 for Q1 2026.

  • Quarterly Gains from Sales and Divestitures changed N/A to $309133.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $309133.0 through Mar 2026, changed N/A year-over-year, with the annual reading at $252814.0 for FY2025, N/A changed from the prior year.
  • Gains from Sales and Divestitures hit $309133.0 in Q1 2026 for Nuvalent, up from $252814.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $309133.0 in Q1 2026 and bottomed at $21129.0 in Q4 2022.
  • Average Gains from Sales and Divestitures over 3 years is $206495.2, with a median of $247859.5 recorded in 2025.